NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/08/2025
Voltar para busca
Dado oficial do USPTO
EXPRESS SCRIPTS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
EXPRESS SCRIPTS
ST13
US500000087585041Classe
35, 36, 44
Pedido
87585041
Registro
5830923
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
49
Atualização mais recente
07/08/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 44
Data de depósito
26/08/2017
Data de registro
13/08/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/08/2025
Última transação
07/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Primeiro uso
01/10/1986
Primeiro uso no comércio
01/10/1986
Código do desenho
4
Tipo de titular
03
Localização do titular
St. Louis, MO
Examinador
FALK,JONATHAN ROBERT
Localização atual
Historical data usage
Titulares e representantes
Titulares
Express Scripts Strategic Development, Inc.
Representantes
Troy E. Larson
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Drug utilization review services; pharmaceutical cost management services; strategic business analysis and business advice regarding pharmacy benefit managementpharmaceutical end-user behaviorhealthcare use behavior; market study and analysis of healthcarehealthcare benefitspharmacy benefits effecting health behavior change and choice at the patient level; market analysis and reporting of the effectiveness of tailored health messaging and support at the patient level; providing information in the field of pharmaceutical cost management as provided to pharmacy benefit management services clientsconsultants and brokers; conducting and arranging business conferences in the field of pharmacy benefit management
Classe 36
Pharmacy benefit management services; pharmacy benefit management consulting services; medical benefit management services; advisory services and consultancy regarding healthcare benefits and pharmacy benefits; provision of information and analysis in the fields of healthcare benefits and pharmacy benefits; medicare prescription coverage plans servicesproviding insurance underwriting and claims administration of medicare prescription drug plans for qualified beneficiaries; administration of pharmacy benefit plans; pharmacy benefit management servicestrackingmonitoringassessing and analyzing information and statistics regarding patient prescription drug use and healthcare habitsproviding a predictive model to determine patients' future prescription drug and healthcare habitsall to identify potential cost savings and for clinical benefits; pharmacy benefit management services for organized labor
Classe 44
Advisory services and consultancy regarding healthcare; Healthcare serviceswellness and disease management programs; medicare prescription coverage plan servicesdisease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication complianceproviding information regarding health and safety issues regarding chronic conditions; providing medical information and analysis in the fields of healthcarepharmaceuticals; providing information in the field of healthcare as provided to pharmacy benefit management services clientsconsultants and brokers
Publicações
Histórico de despachos e eventos da marca no USPTO.
49 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/08/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/08/2025
E815
TEAS SECTION 8 & 15 RECEIVED
02/04/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/09/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
13/08/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
13/08/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/06/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/06/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/05/2019
PUBO
PUBLISHED FOR OPPOSITION
28/05/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/05/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
24/04/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/04/2019
ALIE
ASSIGNED TO LIE
18/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/04/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/04/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/10/2018
GNRT
NON-FINAL ACTION E-MAILED
09/10/2018
CNRT
NON-FINAL ACTION WRITTEN
09/10/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/09/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
22/06/2018
GNFR
FINAL REFUSAL E-MAILED
22/06/2018
CNFR
FINAL REFUSAL WRITTEN
22/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/06/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/12/2017
GNRT
NON-FINAL ACTION E-MAILED
01/12/2017
CNRT
NON-FINAL ACTION WRITTEN
01/12/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
13/11/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
07/11/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
26/10/2017
ALIE
ASSIGNED TO LIE
20/10/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/10/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
06/10/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/10/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
06/10/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/10/2017
DOCK
ASSIGNED TO EXAMINER
04/10/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/08/2017
NWAP
NEW APPLICATION ENTERED
30/08/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EXPRESS SCRIPTS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.